US Stock MarketDetailed Quotes
TNGX Tango Therapeutics
- 7.440
- +0.110+1.50%
Close Apr 26 16:00 ET
- 7.440
- 0.0000.00%
Post 16:13 ET
793.98MMarket Cap-6888P/E (TTM)
7.500High7.260Low301.91KVolume7.370Open7.330Pre Close2.24MTurnover0.66%Turnover RatioLossP/E (Static)106.72MShares13.03052wk High3.14P/B342.44MFloat Cap2.47052wk Low--Dividend TTM46.03MShs Float18.840Historical High--Div YieldTTM3.27%Amplitude2.470Historical Low7.427Avg Price1Lot Size
Tango Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -8.16%-117.98M | 2.83%-27.47M | -58.76%-31.14M | 22.40%-24.47M | -17.67%-34.91M | -83.24%-109.08M | -67.23%-28.27M | 8.76%-19.61M | -319.50%-31.54M | -117.92%-29.67M |
| Net income from continuing operations | 5.95%-101.74M | -5.86%-30.76M | 23.36%-22.26M | 16.69%-20.71M | -11.11%-28.01M | -85.76%-108.18M | -31.82%-29.06M | -48.29%-29.05M | -453.26%-24.86M | -108.23%-25.21M |
| Depreciation and amortization | 50.19%2.42M | 8.25%617K | 47.00%613K | 93.59%604K | 88.03%581K | 79.26%1.61M | 122.66%570K | 85.33%417K | 47.17%312K | 51.47%309K |
| Other non cash items | 107.20%3.63M | 361.62%914K | 14.90%933K | 450.00%1.79M | -102.89%-12K | 32.35%1.75M | -50.99%198K | 162.78%812K | 5.16%326K | 38.33%415K |
| Change In working capital | -105.30%-37.97M | 81.15%-750K | -446.46%-16.02M | 11.53%-9.51M | -39.36%-11.69M | -63.01%-18.49M | -278.63%-3.98M | 178.78%4.62M | -126.69%-10.75M | -183.22%-8.39M |
| -Change in receivables | --2M | --0 | --0 | --0 | --2M | --0 | --0 | --0 | --0 | --0 |
| -Change in prepaid assets | -8.22%-2.23M | 279.26%1.36M | -109.87%-1.12M | 103.58%321K | 24.52%-2.78M | 34.92%-2.06M | -1,301.59%-757K | 501.38%11.35M | -3,306.46%-8.96M | -2,693.18%-3.69M |
| -Change in payables and accrued expense | -142.79%-3.73M | 428.24%3.91M | -161.46%-3.74M | -48.51%1.25M | -898.26%-5.15M | 72.42%8.73M | 85.00%740K | 205.63%6.08M | 222.67%2.42M | -126.86%-516K |
| -Change in other current assets | 99.59%-41K | -98.31%1K | 99.65%-35K | 50.00%6K | -425.00%-13K | -7,096.40%-10M | 137.58%59K | -201,500.00%-10.07M | -20.00%4K | -50.00%4K |
| -Change in other current liabilities | -243.47%-2.44M | -249.87%-586K | -117.95%-392K | -233.41%-1.49M | 106.06%26K | 259.47%1.7M | 207.71%391K | 977.11%2.18M | -443.90%-446K | -15.32%-429K |
| -Change in other working capital | -86.99%-31.53M | -23.12%-5.43M | -118.13%-10.73M | -154.52%-9.6M | -53.43%-5.77M | -40.01%-16.86M | -18.70%-4.41M | -505.61%-4.92M | 26.82%-3.77M | 14.32%-3.76M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -8.16%-117.98M | 2.83%-27.47M | -58.76%-31.14M | 22.40%-24.47M | -17.67%-34.91M | -83.24%-109.08M | -67.23%-28.27M | 8.76%-19.61M | -319.50%-31.54M | -117.92%-29.67M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 56.92%41.43M | 368.56%33.85M | -472.10%-56.66M | -7.91%32.69M | 369.28%31.55M | 114.39%26.4M | 72.12%-12.61M | 110.00%15.23M | 635.74%35.49M | -156.85%-11.72M |
| Net PPE purchase and sale | 80.16%-1.53M | 78.29%-226K | 99.51%-16K | 63.34%-664K | 60.28%-620K | -318.73%-7.69M | -49.57%-1.04M | -323.64%-3.28M | -796.53%-1.81M | -846.06%-1.56M |
| Net investment purchase and sale | 25.99%42.95M | 394.69%34.08M | -406.09%-56.65M | -10.60%33.35M | 416.77%32.17M | 118.77%34.09M | 74.02%-11.56M | 112.22%18.51M | 680.79%37.3M | -148.88%-10.16M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 56.92%41.43M | 368.56%33.85M | -472.10%-56.66M | -7.91%32.69M | 369.28%31.55M | 114.39%26.4M | 72.12%-12.61M | 110.00%15.23M | 635.74%35.49M | -156.85%-11.72M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 5,002.54%82.41M | 178.37%1.47M | 70,944.25%80.28M | -18.38%586K | -71.60%73K | -99.55%1.62M | 539.17%527K | -99.97%113K | 196.25%718K | -99.15%257K |
| Net common stock issuance | --80.02M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 19.59%1.94M | 59.58%841K | 290.27%441K | -18.38%586K | -72.45%73K | 53.40%1.62M | 421.78%527K | -41.45%113K | 120.92%718K | -39.64%265K |
| Net other financing activities | 5,700.00%448K | --626K | ---- | ---- | ---- | 99.95%-8K | --0 | --0 | --0 | 69.23%-8K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 5,002.54%82.41M | 178.37%1.47M | 70,944.25%80.28M | -18.38%586K | -71.60%73K | -99.55%1.62M | 539.17%527K | -99.97%113K | 196.25%718K | -99.15%257K |
| Net cash flow | ||||||||||
| Beginning cash position | -55.90%63.96M | -40.60%61.96M | -36.01%69.48M | -41.60%60.68M | -55.90%63.96M | 373.01%145.02M | -49.67%104.3M | 104.16%108.57M | 52.64%103.9M | 373.01%145.02M |
| Current changes in cash | 107.22%5.85M | 119.46%7.85M | -76.09%-7.52M | 88.32%8.8M | 92.02%-3.28M | -170.88%-81.07M | 35.17%-40.34M | -102.77%-4.27M | 131.39%4.67M | -209.93%-41.13M |
| End cash Position | 9.15%69.81M | 9.15%69.81M | -40.60%61.96M | -36.01%69.48M | -41.60%60.68M | -55.90%63.96M | -55.90%63.96M | -49.67%104.3M | 104.16%108.57M | 52.64%103.9M |
| Free cash flow | -2.34%-119.51M | 5.51%-27.69M | -36.09%-31.15M | 24.62%-25.14M | -13.77%-35.53M | -90.29%-116.77M | -66.54%-29.31M | -2.79%-22.89M | -331.98%-33.35M | -126.64%-31.23M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg